Uterine artery endothelial production of the potent vasodilator, prostacyclin, is greater in pregnant versus nonpregnant sheep and in whole uterine artery from intact versus ovariectomized ewes. We hypothesized that uterine artery cyclooxygenase (COX)-1 and/or COX-2 expression would be elevated during pregnancy (high estrogen and progesterone) and the follicular phase of the ovarian cycle (high estrogen/low progesterone) as compared to that in luteal phase (low estrogen/high progesterone) or in ovariectomized (low estrogen and progesterone) ewes. Uterine and systemic (omental) arteries were obtained from nonpregnant luteal-phase (LUT; n ‫؍‬ 10), follicular-phase (FOL; n ‫؍‬ 11), and ovariectomized (OVEX; n ‫؍‬ 10) sheep, as well as from pregnant sheep (110-130 days gestation; term ‫؍‬ 145 ؎ 3 days; n ‫؍‬ 12). Endothelial and vascular smooth muscle (VSM) COX-1 protein levels and uterine artery endothelial cell COX-1 mRNA levels were compared. Using immunohistochemistry and Western analysis, the primary location of COX-1 protein was the endothelium; that is, we observed 2.2-fold higher COX-1 protein levels in intact versus endotheliumdenuded uterine artery and a 6.1-fold higher expression in the endothelium versus VSM (P Ͻ 0.05). COX-2 protein expression was not detectable in either uterine artery endothelium or VSM. COX-1 protein levels were observed to be higher (1.5-fold those of LUT) in uterine artery endothelium from FOL versus either OVEX or LUT nonpregnant ewes (P Ͻ 0.05), with substantially higher COX-1 levels seen in pregnancy (4.8-fold those of LUT). Increases in uterine artery endothelial COX-1 protein were highly correlated to increases in the level of COX-1 mRNA (r 2 ‫؍‬ 0.66; P Ͻ 0.01) for all treatment groups (n ‫؍‬ 6-8 per group), suggesting that increased COX-1 protein levels are regulated at the level of increased COX-1 mRNA. No change in COX-1 expression was observed between groups in a systemic (omental) artery. In conclusion, COX-1 expression is specifically up-regulated in the uterine artery endothelium during high uterine blood flow states such as the follicular phase and, in particular, pregnancy.
INTRODUCTION
During human and ovine pregnancy, there is an increase in uteroplacental blood flow and cardiac output, along with 1 Supported by NIH HL49210, HL57653, HD33255, HL56702, WI Perinatal Foundation, and USDA 97352044912 and 960177. This study was presented at the 45th Annual Meeting of the Society for Gynecologic Investigation, Atlanta, GA, March 11-14, 1998. an attenuated pressor response to the vasoconstrictive effects of angiotensin II [1] [2] [3] [4] [5] . Moreover, the uterine vascular bed is less responsive to vasoconstriction by angiotensin II than the systemic vascular bed [1, 5] . This vascular refractoriness to angiotensin II is at least partially mediated by the potent vasodilator prostacyclin (PGI 2 ) [6] [7] [8] . In pregnancy, PGI 2 is increased in systemic plasma, uterine venous blood, and urine [3, 6] . Moreover, we have previously shown that during ovine pregnancy, the uteroplacental unit is a major source of the elevated circulating concentrations of PGI 2 [1, 3] . Cyclooxygenase (COX) is a rate-limiting enzyme in the production of PGI 2 ; and the potent inhibitor of this enzyme, indomethacin, increases both the systemic pressor effects [7, 8] and the uterine vasoconstrictor responses induced by i.v. infusions of angiotensin II [1, 8] . Thus the pregnancy-associated refractoriness to the vasoconstrictor effects of infused angiotensin II may be related to elevated local uterine and systemic levels of vasodilating prostaglandins such as PGI 2 [1] [2] [3] [4] [5] [6] [7] [8] .
In both pregnant and nonpregnant sheep, PGI 2 is the primary prostaglandin produced by uterine artery endothelial cells, with only small quantities derived from the vascular smooth muscle (VSM) [9] [10] [11] [12] [13] . Previously we have shown that the de novo production of PGI 2 in vitro by uterine artery endothelium from pregnant sheep is greater than that observed for nonpregnant ewes [10] [11] [12] , although the magnitude of the pregnancy-related increase was greater (5-to 6-fold) when compared to that in the uterine arteries obtained from ovariectomized sheep [10] rather than ovaryintact sheep [11, 14] . Moreover, production of PGI 2 by uterine arteries placed in tissue culture was less in ovariectomized as compared to intact sheep [14] and in uterine arteries from postmenopausal versus premenopausal women [15] . Therefore, changes in PGI 2 production during pregnancy and the ovarian cycle may be regulated, in part, via increases in the activity and/or the expression of COX-1 at the level of protein and mRNA. This theory is supported by the proportionally greater PGI 2 production by uterine arteries from pregnant versus nonpregnant ewes during incubation in the presence of excess arachidonic acid, the substrate for COX [11] . Previously we have shown, in freshly isolated uterine artery endothelial cells from pregnant and nonpregnant sheep, that COX-1 expression is elevated at the level of both protein and mRNA in pregnancy [16] . However, since pregnancy is a state of both high estrogen and progesterone, it is possible that either or both of these steroid hormones are responsible for this response [2, [17] [18] [19] . During the follicular phase of the ovarian cycle there is also an increase in uterine blood flow, whereas decreases are observed during the luteal phase [17, 20] . In contrast to the pregnant state, however, the follicular phase is characterized as an estrogen-dominated state, and the luteal phase is a progesterone-dominated state [18, 21] .
Cyclooxygenase exists in two isoforms, COX-1 and COX-2 [22] . COX-1 is ''constitutively'' expressed in many tissues [23] including uterine tissues (endometrium and myometrium; [24] [25] [26] [27] ), as well as in pulmonary endothelial cells of ovine fetuses and lambs, in which it appears to regulate vascular homeostasis via production of prostanoids [28] . In contrast, COX-2 is induced by mitogens, lipopolysaccharides, and hCG in various tissues and is usually associated with inflammatory responses [13, [29] [30] [31] [32] . COX-2 is also strongly induced in the uterus and placenta near term and during labor [24, 25, 33, 34] . It is not known, however, whether COX expression is also quantitatively regulated in uterine and systemic artery endothelium and VSM during the ovarian cycle and pregnancy.
In the current study we tested the hypothesis that during physiologic states that have high uterine blood flow, such as the follicular phase of the ovarian cycle [2, 17, 20] and pregnancy [2, 3, 17] , there is an increase in uterine artery endothelial COX-1 and/or COX-2 expression. Our specific objectives were the following: 1) to localize the presence of COX-1 and COX-2 in the uterine arterial wall (endothelium versus VSM); 2) to determine whether there is a change in the uterine and/or systemic (omental) arterial expression of COX-1 and/or COX-2 in ovariectomized, follicular-phase, and luteal-phase sheep and to compare any such changes to those that occur in pregnant sheep; and 3) to determine whether changes in COX-1 protein expression could be due to underlying changes in COX-1 mRNA level. Clearly, knowledge of the magnitude and cellular location of any changes in uterine artery COX-1 and/or COX-2 expression in various physiological states would provide valuable insight into the possibility that endogenous ovarian/ placental steroid-dependent mechanisms underlie control of uterine artery function and uterine blood flow.
MATERIALS AND METHODS
Synchronization of Follicular-and Luteal-Phase Ewes [13, 14, 18, 35] Polypay and mixed western breed ewes, 50-60 kg (n ϭ 21) were observed daily for signs of behavioral estrus in the presence of a vasectomized ram. Ewes exhibiting normal estrous cycles (16-18 days) were given 2 injections i.m., 5 mg each, of prostaglandin F 2␣ (PGF 2␣ , Lutalyse; UpJohn, Kalamazoo, MI) 4 h apart in order to rapidly induce luteolysis, and the ewes were monitored for behavioral estrus beginning 40-44 h after the first PGF 2␣ injection. Ewes exhibiting estrus (Day 0) were randomly assigned into two groups, follicular (Day Ϫ1 to 0, n ϭ 11) or luteal (Day 10, n ϭ 10). On Day 8 of the estrous cycle, the ewes assigned to the follicular group were given PGF 2␣ , as described above, and the ewes assigned to the luteal group were given saline (2 injections i.m., volume equivalent to that for PGF 2␣ , 4 h apart). With this synchronization protocol, ewes show estrus within 44-56 h after the first PGF 2␣ injection. Follicular-phase ewes were killed 44 h after the first injection of PGF 2␣ , and the luteal-phase ewes were killed that same day at 44 h after the first saline injection.
Ovarian Structures
The diameters and presence of the ovarian corpora lutea and follicles were determined as previously described [13, 14, 18, 35] . Small (1-3 mm), medium (4-5 mm), and large (Ն 6 mm) follicles were measured and recorded. Lutealphase ewes had significantly larger-diameter (9.6 Ϯ 0.5 mm) and vascular corpora lutea as compared to follicularphase ewes (P Ͻ 0.01), whose regressing corpora lutea (corpora albicans) were smaller (6.4 Ϯ 0.4 mm), blanched, and avascular. Although the follicular-phase ewes had similar numbers of small and medium follicles, their large follicles had greater (P Ͻ 0.05) diameters (8.1 Ϯ 0.7 mm) than those in the luteal-phase sheep (6.5 Ϯ 0.3 mm). These data validate that the follicular-phase sheep were in a highestrogen condition while the luteal-phase sheep were in a high-progesterone state, as previously reported [13, 14, 18, 35] . We also have previously reported the circulating estrogen and progesterone plasma levels using this animal model [18] .
Ovariectomized Ewes
Polypay and mixed western breed ewes (50-60 kg; n ϭ 10) that had previously had normal estrous cycles underwent uncomplicated ovariectomy (OVEX) using a midventral laparotomy under general anesthesia as previously described [14, 35] . Sheep underwent nonsurvival surgery on Days 10-11 postovariectomy, and the arteries were obtained as described below.
Tissue Collection
Polypay and mixed western breed sheep were bred at the University of Wisconsin-Madison Animal Sciences facility designated for these studies in order to obtain pregnant ewes (n ϭ 12) at 120-130 days gestation. Procedure for animal handling and protocols for experimental procedures were approved by the University of Wisconsin-Madison Research Animal Care and Use Committees of both the Medical School and College of Agriculture and Life Sciences, and followed the 1993 ''Report of the American Veterinary Medical Association Panel on Euthanasia.'' All ewes in this experiment were administered general anesthesia consisting of i.v. sodium pentobarbital (40-50 mg/ kg) and then underwent nonsurvival surgery at the conclusion of the procedure. The uterine mesometrium, containing a portion of the main uterine artery, was removed rapidly (10-12 min) and placed in sterile PBS (pH 7.40) containing NaCl (137 mM), KCl (2.7 mM), Na 2 HPO 4 ·7H 2 O (4.3 mM), and KH 2 PO 4 (1.4 mM). Further dissection of arteries to remove fat and connective tissue was performed at 25ЊC in Petri dishes containing PBS. During dissection, the PBS was removed from the dish and replaced three times. The methods for the preparation of the intact or endotheliumdenuded uterine or omental arterial segments, or direct mechanical isolation of endothelial protein for SDS-PAGE electrophoresis and Western immunoblotting, were reported by and validated previously in this laboratory [14, 16, [35] [36] [37] . Additional arterial segments were either subjected to collagenase dispersion or fixed for immunohistochemistry, as described below.
Western Immunoblot Analysis
The protocol for SDS-PAGE on 7.5% gels as well as subsequent Western immunoblot analysis, as described previously [14, 16, [35] [36] [37] , was performed for 6 sheep in each of the OVEX, follicular-phase (FOL), and luteal-phase (LUT) groups and for 8 pregnant (PREG) sheep. COX-1-specific antiserum (Cayman Chemical Company, Ann Arbor, MI) was utilized at a dilution of 1:3000 overnight at room temperature, and a secondary antibody (sheep antimouse Fab2-horseradish peroxidase conjugate; Amersham; now Amersham Pharmacia Biotech, Piscataway, NJ) was used at 1:5000 dilution for 1 h. A positive control for COX-1, ram seminal vesicle (RSV), was included on each blot. Specific binding for COX-1 was detected using enhanced chemiluminescence reagent detection system, as described by Amersham, and exposed to Hyperfilm (5 min). Levels of COX-1 were quantified by scanning densitometry (BioRad 670 scanning densitometer; Richmond, CA) and expressed relative to mean luteal absorbance.
COX-2-specific antiserum was rabbit polyclonal antibody (Cayman) at a dilution of 1:4000, and the secondary antibody was a goat anti-rabbit horseradish peroxidase conjugated (Amersham) at a dilution of 1:8000. The control for COX-2 was purified COX-2 from sheep cotyledons (Cayman). This COX-2 antibody has previously been shown to detect only COX-2, without any cross reaction with COX-1 [13, 14, 16] .
Immunohistochemistry
Immunohistochemistry methods were similar to those we have previously reported [13, 16, [35] [36] [37] and were performed on representative uterine arteries from 4 to 5 ewes in each of the four treatment groups. Arteries were placed in 4% formaldehyde in sodium cacodylate buffer (0.1 M, pH 7.4) and fixed overnight. Tissues were sequentially dehydrated in graded ethanol solutions, embedded in paraffin, cut into sections (6 m), and mounted on polylysine-coated glass slides. After deparaffinization and graded rehydration, sections were incubated in hyaluronidase for 30 min at 37Њ, followed by 3% H 2 O 2 in 60% methanol for 20 min to quench endogenous peroxidase activity. COX-1 antibody (mouse monoclonal antibody; Cayman) was then applied (1:2000 dilution), and staining was detected using a biotinylated secondary antibody in combination with the avidinbiotin-peroxidase method (Elite ABC kit; Vector Laboratories, Burlingame, CA) with 3,3Ј-diaminobenzidine as chromagen. As controls, adjacent sections were alternatively treated with a control mouse IgG fraction (2.5 mg/ml; Vector), without primary antisera, or without second antibody. These control sections were routinely stained in parallel with each batch of uterine artery slides prepared from ovariectomized (n ϭ 5) and nonpregnant, follicular-phase (n ϭ 5) and luteal-phase (n ϭ 4) animals, as well as from pregnant (n ϭ 4) animals.
Isolation of Endothelial Cells and Cellular RNA
Uterine artery endothelial cells were isolated by collagenase dispersion as previously described [16, 37, 38 ] from 6 each of the ovariectomized, follicular-phase, and lutealphase sheep and from 8 of the pregnant sheep. These freshly isolated endothelial cells were solubilized in RNAzol B (1 ml), and 150 l chloroform was added to promote phase separation followed by centrifugation (12 000 ϫ g, 20 min). The upper aqueous phase was then removed, extracted twice with phenol/chloroform/isoamyl alcohol using heavy grade phase-lock gel (Eppendorf 5-Prime, Boulder, CO), and finally mixed with 110% by volume of isopropanolol. RNA was precipitated by standing at Ϫ20ЊC for 1 h before recovery by centrifugation (12 000 ϫ g, 30 min) and washing of the pellet in 75% ethanol. RNA was then solubilized in molecular biology grade water (5-Prime) and quantified by spectrophotometry before storage at Ϫ70ЊC.
COX-1 Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Assay
COX-1 mRNA levels were quantified by coupled RT-PCR amplification in single-tube assays using avian myeloblastosis virus reverse transcriptase and Taq polymerase, essentially as described previously for ovine COX-1 [16] . Total cellular RNA (0.5 g/tube) was incubated in a 50-l final volume containing single-strength PCR buffer, 2 mM MgCl 2 , 10 nmol each dATP, dTTP, dCTP, dGTP, and 30 pmol each of forward and reverse temperature-matched primers, targeting amplification of 313 bases of the ovine COX-1 mRNA for 29 cycles. All data in each group were normalized to the mean glyceraldehyde-3-phosphate dehydrogenase content of each sample within each subgroup, determined by RT-PCR as previously described [38] . The standard curve for the COX-1 RT-PCR assay and the high degree of linearity were demonstrated in our previous publications using identical conditions [16] .
Statistical Analysis
Data were analyzed by ANOVA or Student's t-test when applicable (SigmaStat; Jandel Scientific, San Rafael, CA). When ANOVA was significant, treatment means were compared using Bonferroni's multiple comparison test. A linear correlation was determined between COX-1 mRNA and protein using the least-squares method. Data are reported as means and SEM, and significance was accepted at P Ͻ 0.05.
RESULTS

Western Immunoblot Analysis
The COX-1 protein was detected at 70 kDa in agreement with the standard from RSV lysate. A standard curve was generated to ensure that COX-1 was detected in a linear fashion and consistent with our previous data [16] ; to confirm that we were not detecting COX-2, we probed the blot specifically for that enzyme and obtained negative results (data not shown). The majority of COX-1 level in uterine arteries was consistently observed in the endothelium, as compared with the VSM (Fig. 1) . Scanning densitometry showed 2.2-fold greater COX-1 levels in the intact versus denuded uterine arteries (VSM) and 6.1-fold greater levels in the endothelium compared to the VSM (P Ͻ 0.05).
While luteal-phase and ovariectomized sheep showed no difference in COX-1 expression in uterine artery endothelium, significantly more COX-1 was observed in follicularphase ewes as compared to luteal-phase animals (Fig. 2,  1 .5-fold the luteal level, P Ͻ 0.05). In addition, COX-1 expression in the uterine artery endothelium from pregnant ewes was substantially higher than in follicular-phase, luteal-phase (4.8-fold of luteal), or ovariectomized animals (P Ͻ 0.001). In contrast, the level of COX-1 detected in uterine artery VSM was very low, and there did not appear to be any major changes in COX-1 protein levels in VSM with treatment group (data not shown). Moreover, omental (systemic) artery endothelial COX-1 protein expression by Western immunoblot analysis was not significantly altered (P Ͼ 0.05) by ovariectomy, the phase of the ovarian cycle, or pregnancy (i.e., pregnant, follicular, and ovariectomized expressions were 0.547-, 1.27-, and 1.5-fold the luteal expression, respectively). These data suggest that the above changes in COX-1 expression between groups were specific to the uterine vasculature. Again as with the uterine artery VSM, COX-1 levels in omental artery VSM were compar- atively extremely low and did not appear to change with treatment (data not shown).
Immunohistochemistry
Since the Western immunoblot data showed that the majority of the COX-1 protein was observed in the uterine artery endothelium, we confirmed this finding with immunohistochemistry (Fig. 3) . The darkest staining for COX-1 was immunolocalized in the uterine artery endothelium, with some small amount of staining in the VSM. Furthermore, consistent with the Western immunoblot data shown in Figure 2 , the arteries from the pregnant sheep and the follicular animals exhibited the most intense COX-1 staining with immunohistochemistry (Fig. 3) . In addition, the uterine arteries from the luteal and ovariectomized animals stained the least, and there did not appear to be any substantial differences between these two groups. In some of the cross sections it appeared that the ovariectomized group may have had a little less staining than the luteal-phase group. We observed no immunostaining in the control segments in which either the primary antibody or the secondary antibody had been replaced with the nonimmune IgG serum. Because seminal vesicles are known to express large amounts of COX-1, but not COX-2 [16] , we further validated this COX-1 antiserum by immunohistochemically staining rat seminal vesicles. This positive control intensely stained for COX-1 (data not shown).
COX-1 mRNA RT-PCR
RT-PCR was utilized to quantify COX-1 mRNA in collagenase-dispersed isolated uterine artery endothelial cells (Fig. 4) obtained from ovariectomized ewes (n ϭ 6), as well as from sheep during the follicular and luteal phases of the ovarian cycle (n ϭ 6 per group) and in pregnancy (n ϭ 8). We observed relative levels of total COX-1 mRNA isolated from uterine artery endothelial cells similar to those from Western analysis except in the OVEX group; i.e., the rank order of COX-1 mRNA levels was PREG ϾϾϾ FOL Ն LUT Ͼ OVEX. The uterine artery endothelial COX-1 mRNA levels in follicular-and luteal-phase animals were both significantly greater than in OVEX controls; follicular levels tended to be greater than luteal-phase levels, but without achieving statistical significance. The level of COX-1 mRNA for pregnant ewes was substantially higher than that observed in all other groups. In the current study, however, we were further able to evaluate paired uterine artery endothelial COX-1 mRNA and protein samples from the same 6 sheep per nonpregnant group (OVEX, FOL, and LUT) as well as 8 pregnant sheep in order to study more directly the relationship between COX-1 mRNA and protein expression (Fig. 5 ). There was a significant linear correlation (r 2 ϭ 0.66) between COX-1 mRNA and protein across all groups, strongly suggesting that COX-1 expression is at least partly regulated at the mRNA level.
DISCUSSION
Uterine blood flow is increased greatly during pregnancy, which is a physiologic state of high circulating levels of estrogen and progesterone [2, 3, [17] [18] [19] . Uterine perfusion also is elevated during the follicular phase of the ovarian cycle, when estrogen is the predominant ovarian steroid, versus the luteal phase, when progesterone predominates [17, 18, 21] . Since estrogen is known to be a potent uterine vasodilator [35, [39] [40] [41] , this may explain the observation that uterine arterial tone is low during the follicular phase of the ovine and bovine estrous cycle and is increased during the luteal phase when progesterone dominates [17] . Ovariectomy is a state of hormone deprivation, similar to that observed in menopause [14, 15, 40] , and systemic administration of estrogen has also been shown to increase uterine blood flow in ovariectomized sheep [35, [39] [40] [41] .
The production of the potent vasodilator PGI 2 [1, 3] by the uterine vascular bed may be an important mediator of vascular tone during the follicular phase of the ovarian cycle [17] . In view of the direct relationship between elevations in the estrogen-to-progesterone ratio and uterine blood flow during the follicular phase of the ovarian cycle [17, 18, 20, 21, 35] , we were particularly interested in the effects that the phase of the ovarian cycle and ovariectomy had on endothelial and VSM expression of COX-1. We were unable to detect significant levels of COX-2 by Western blot analysis, confirming our recent findings that COX-2 protein expression in whole uterine arteries obtained from nonpregnant ewes in tissue culture was undetectable as compared to COX-1 levels. The observations that COX-1, but not COX-2, is expressed by ovine uterine artery endothelium and VSM have also been obtained immunohistochemically in luteal-and follicular-phase [13] as well as ovariectomized [26] sheep. We also demonstrated that COX-2 levels were specifically and dramatically elevated only in the presence of lipopolysaccharide [13, 14] . The current study, however, focused exclusively on the expression of COX in the basal state, and so focused on COX-1. These results were compared to those of pregnancy, a state of high estrogen and progesterone [2, [17] [18] [19] as well as elevated uterine artery endothelial PGI 2 production [10] [11] [12] .
Using immunohistochemistry we have extended our previous studies [16] to demonstrate that the expression of COX-1 is primarily seen in the endothelium-more so than in the VSM in all treatment groups. Consistent with this we have further demonstrated for the first time using Western immunoblot analysis that COX-1 expression was reduced considerably in denuded uterine arteries (VSM) as compared to intact vessels ( Fig. 1) and that, while COX-1 is expressed in the VSM, its levels were 6.1-fold greater in endothelial-isolated protein preparations. Bovine aortic endothelial cells have also been shown to contain 20-fold higher concentrations of COX-1 than the VSM [42, 43] . These current observations are also consistent with previous studies [11, 12] from our laboratory showing that endothelium removal decreased PGI 2 production by about 70%, suggesting that the uterine artery endothelium, to a greater extent than VSM, is the primary source of PGI 2 production and COX-1 in both nonpregnant and pregnant sheep.
In the present study, we have clearly established the relative COX-1 protein levels by Western immunoblot analysis in uterine artery endothelium from ovariectomized, follicular-phase, luteal-phase, and pregnant ewes (Fig. 2) . The relative order of protein expression for COX-1 in endothelium was PREG ϾϾϾ FOL Ͼ LUT ϭ OVEX. We thus report for the first time that COX-1 protein levels in follicular-phase animals are significantly elevated above those for luteal-phase animals; however, they are substantially increased over luteal-and follicular-phase levels by pregnancy. The observation FOL Ͼ LUT is consistent with previous reports by Chang et al. [44, 45] , who showed that estradiol-17␤ increased PGI 2 synthesis and COX-specific activity in rat aortic smooth muscle cells, and also with findings of Jun et al. [46] , who recently demonstrated that estradiol-17␤, acting through its receptor, increases the activity and mRNA and protein levels of COX-1 in cultured ovine fetal pulmonary artery endothelial cells. In contrast, when we compared ovine uterine artery PGI 2 production and COX-1 protein levels after 24 h in tissue culture, we did not detect any difference when arteries were collected 2 h after vehicle versus estradiol-17␤ treatment [14] . We also did not significantly alter uterine artery endothelial COX-1 expression with 10 days of continuous estradiol-17␤ or progesterone treatment alone, whereas the combination of estradiol-17␤ and progesterone did significantly increase COX-1 levels in uterine artery endothelium (unpublished results). In this regard, this latter comparison (estrogen plus progesterone) is consistent with our current and previous studies demonstrating that production of PGI 2 and COX-1 expression by uterine artery endothelium was increased by pregnancy [10] [11] [12] 14] , a state of elevated estrogen and progesterone levels [2, [17] [18] [19] . The increase in COX-1 protein levels observed during the follicular phase was not as great as that observed during pregnancy, suggesting that progesterone [2, 17, 18 ]-in combination with other components in pregnancy such as growth factors [2, [47] [48] [49] , shear stress [50] , or the length of time of exposure [2, 40, 41] to placental steroids (120-130 days)-caused the greater COX-1 elevation during gestation. Our previous studies also indicated that the production of PGI 2 by uterine arteries from ovariectomized sheep was less than that from intact nonpregnant sheep [10] [11] [12] 14] . As evidenced by these findings, and in contrast to our hypothesis, the levels of COX-1 protein expression in endothelial-isolated protein were not significantly decreased in the OVEX group. It is possible that differences in the length of time postovariectomy in the two studies was responsible for the discrepant findings between uterine artery endothelial PGI 2 production [10-12, 14] and COX-1 protein expression (Fig. 2) .
We previously reported that omental artery endothelial PGI 2 production [10] [11] [12] was increased in pregnant versus nonpregnant sheep, both in the absence and in the presence of saturating doses of arachidonate in vitro [11] , suggesting that either the omental artery COX-1 expression or activity was increased with gestation. In the present study, we directly addressed the former and observed that the expression of COX-1 in omental (systemic) artery endothelialisolated protein was not significantly altered by ovariectomy, the stage of the ovarian cycle, or pregnancy. These data also demonstrate that the increase in this systemic artery vasodilator during pregnancy cannot be explained by changes in the levels of the COX-1 protein; they rather suggest either an increased COX-1-specific activity or increased substrate release from membrane phospholipids. In recent studies we have observed that although the omental artery endothelial protein level of phospholipase A 2 was unaltered [51] by pregnancy, the expression of PGI 2 synthase protein was increased significantly [52] . The relative pattern of COX-1 mRNA across all groups was highly correlated with protein levels in the endothelium collected from the same animals. Unlike findings for the protein levels, however, while the rank order for COX-1 mRNA was PREG ϾϾϾ FOL Ն LUT, the level in OVEX ewes was lower than in both follicular-and luteal-phase sheep (P Ͻ 0.05). The dramatic increase in COX-1 mRNA during pregnancy confirms our previous observations [16] . The follicular-phase COX-1 mRNA was slightly, but not significantly, higher than the luteal-phase value, which otherwise related well to our observations of COX-1 protein levels by both Western analysis and immunohistochemistry. The significant difference in results for LUT versus OVEX at the level of mRNA alone, however, did not prevent a highly significant overall correlation (r 2 ϭ 0.66) of COX-1 mRNA versus protein levels in uterine artery endothelium from the same ewes across all treatment groups (Fig. 5) . Thus we conclude that changes in COX-1 protein are largely driven at the level of changes in COX-1 mRNA. Other posttranscriptional or translational mechanisms may play a role in COX-1 expression, and this may explain the discrepancy between COX-1 protein levels and mRNA expression in the OVEX and LUT groups.
In conclusion, we have shown that in physiologic states of high uterine blood flow and estrogen such as the follicular phase of the ovarian cycle [17] [18] [19] [20] 35] , as well as pregnancy [2, 3] , uterine artery endothelial COX-1 protein and mRNA are significantly elevated. Moreover, the increase in COX-1 expression in the follicular phase and pregnancy was specific to the uterine vascular bed and was not observed in the omental (systemic) arteries. This supports the hypothesis that uterine artery endothelial-derived COX-1 is, at least in part, regulated by the production of estrogen and/ or progesterone. In contrast to our hypothesis regarding the ovariectomized state, which is estrogen and progesterone deficient and which exhibits reduced uterine artery PGI 2 production [14, [39] [40] [41] , there was not a significantly drop in uterine artery endothelial COX-1 protein levels; this suggests that other additional mechanisms remain to be identified. The increase in COX-1 protein levels observed during pregnancy was also greater than that observed during the follicular phase, demonstrating that several interacting factors in pregnancy (e.g., progesterone, growth factors, shear stress, etc.) contribute to the greater elevation of COX-1 expression.
